Listeria monocytogenes-induced cell death inhibits the generation of cell- mediated immunity

Infection and Immunity

Volumn 85, Issue 1, 2017, Pages

  Theisen, Erin ^a   Sauer, John Demian ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Apoptosis; Cell death; Immunotherapy; Inflammasome; Listeria monocytogenes

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BONE MARROW DERIVED MACROPHAGE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PYROPTOSIS; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; IMMUNOLOGY; MICROBIOLOGY;

CD8 ANTIGEN;

ANIMALS; ANTIGENS, CD8; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; FEMALE; IMMUNITY, CELLULAR; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED C57BL; PYROPTOSIS;

EID: 85009127185     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00733-16     Document Type: Article

References (75)

1. Le DT, Dubensky TW, Brockstedt DG. 2012. Clinical development of Listeria monocytogenes-based immunotherapies. Semin Oncol 39: 311-322. https://doi.org/10.1053/j.seminoncol.2012.02.008.
2. Le DT, Wang-Gillam A, Picozzi V, Greten TF, Crocenzi T, Springett G, Morse M, Zeh H, Cohen D, Fine RL, Onners B, Uram JN, Laheru DA, Lutz ER, Solt S, Murphy AL, Skoble J, Lemmens E, Grous J, Dubensky T, Brockstedt DG, Jaffee EM. 2015. Safety and survival with GVAX pancreas prime and Listeria monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. J Clin Oncol 33: 1325-1333. https://doi.org/10.1200/JCO.2014.57.4244.
3. Witte CE, Archer KA, Rae CS, Sauer J-D, Woodward JJ, Portnoy DA. 2012. Innate immune pathways triggered by Listeria monocytogenes and their role in the induction of cell-mediated immunity. Adv Immunol 113: 135-156. https://doi.org/10.1016/B978-0-12-394590-7.00002-6.
4. Janda J, Schöneberger P, Skoberne M, Messerle M, Rüssmann H, Geginat G. 2004. Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products. J Immunol 173: 5644-5651. https://doi.org/10.4049/jimmunol.173.9.5644.
5. Reinicke AT, Omilusik KD, Basha G, Jefferies WA. 2009. Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes. PLoS One 4:e7210. https://doi.org/10.1371/journal.pone.0007210.
6. Guzmán CA, Domann E, Rohde M, Bruder D, Darji A, Weiss S, Wehland J, Chakraborty T, Timmis KN. 1996. Apoptosis of mouse dendritic cells is triggered by listeriolysin, the major virulence determinant of Listeria monocytogenes. Mol Microbiol 20:119-126. https://doi.org/10.1111/j.1365-2958.1996.tb02494.x.
7. Zwaferink H, Stockinger S, Reipert S, Decker T. 2008. Stimulation of inducible nitric oxide synthase expression by beta interferon increases necrotic death of macrophages upon Listeria monocytogenes infection. Infect Immun 76:1649-1656. https://doi.org/10.1128/IAI.01251-07.
8. Sauer J-D, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA. 2010. Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7:412-419. https://doi.org/10.1016/j.chom.2010.04.004.
9. Merrick JC, Edelson BT, Bhardwaj V, Swanson PE, Unanue ER. 1997. Lymphocyte apoptosis during early phase of Listeria infection in mice. Am J Pathol 151:785-792.
10. Gengenbacher M, Nieuwenhuizen N, Vogelzang A, Liu H, Kaiser P, Schuerer S, Lazar D, Wagner I, Mollenkopf H-J, Kaufmann SHE. 2016. Deletion of nuoG from the vaccine candidate Mycobacterium bovis BCG ?ureC::hly improves protection against tuberculosis. mBio 7:e00679-16. https://doi.org/10.1128/mBio.00679-16.
11. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. 2000 Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-434. https://doi.org/10.1084/jem.191.3.423.
12. Green DR, Ferguson T, Zitvogel L, Kroemer G. 2009. Immunogenic and tolerogenic cell death. Nat Rev Immunol 9:353-363. https://doi.org/10.1038/nri2545.
13. Fink SL, Cookson BT. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73:1907-1916. https://doi.org/10.1128/IAI.73.4.1907-1916.2005.
14. Festjens N, Vanden Berghe T, Vandenabeele P. 2006. Necrosis, a wellorchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta 1757: 1371-1387. https://doi.org/10.1016/j.bbabio.2006.06.014.
15. Barker RN, Erwig L, Pearce WP, Devine A, Rees AJ. 1999. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 67:302-305.
16. Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van Kooten C. 2006 IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107:4930-4937. https://doi.org/10.1182/blood-2005-10-4144.
17. Zitvogel L, Casares N, Péquignot MO, Chaput N, Albert ML, Kroemer G. 2004 Immune response against dying tumor cells. Adv Immunol 84: 131-179. https://doi.org/10.1016/S0065-2776(04)84004-5.
18. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G. 2005 Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202:1691-1701. https://doi.org/10.1084/jem.20050915.
19. Cookson BT, Brennan MA. 2001. Pro-inflammatory programmed cell death. Trends Microbiol 9:113-114.
20. Fink SL, Cookson BT. 2007. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol 9:2562-2570. https://doi.org/10.1111/j.1462-5822.2007.01036.x.
21. Lamkanfi M, Sarkar A, Vande Walle L, Vitari AC, Amer AO, Wewers MD, Tracey KJ, Kanneganti T-D, Dixit VM. 2010. Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol 185: 4385-4392. https://doi.org/10.4049/jimmunol.1000803.
22. Fink SL, Cookson BT. 2006. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8:1812-1825. https://doi.org/10.1111/j.1462-5822.2006.00751.x.
23. Suschak JJ, Wang S, Fitzgerald KA, Lu S. 2014. Identification of Aim2 as a sensor for DNA vaccines. J Immunol 194:630-636. https://doi.org/10.4049/jimmunol.1402530.
24. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 206:79-87. https://doi.org/10.1084/jem.20081667.
25. Sagoo P, Garcia Z, Breart B, Lemaître F, Michonneau D, Albert ML, Levy Y, Bousso P. 2016. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity. Nat Med 22:64-71. https://doi.org/10.1038/nm.4016.
26. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini J-L, Schlemmer F, Tasdemir E, Uhl M, Génin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, André F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L. 2009. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15:1170-1178. https://doi.org/10.1038/nm.2028.
27. Matzinger P. 2002. The danger model: a renewed sense of self. Science 296:301-305. https://doi.org/10.1126/science.1071059.
28. Janeway CA. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54(Part 1): 1-13.
29. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, Beg AA. 2001. An essential role of the NF-B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 166:7128-7135. https://doi.org/10.4049/jimmunol.166.12.7128.
30. Epelman S, Liu PP, Mann DL. 2015. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol 15:117-129. https://doi.org/10.1038/nri3800.
31. Curtsinger JM, Schmidt CS, Mondino A, Lins DC, Kedl RM, Jenkins MK, Mescher MF. 1999. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162:3256-3262.
32. Ashida H, Mimuro H, Ogawa M, Kobayashi T, Sanada T, Kim M, Sasakawa C. 2011. Cell death and infection: a double-edged sword for host and pathogen survival. J Cell Biol 195:931-942. https://doi.org/10.1083/jcb.201108081.
33. Brockstedt DG, Giedlin MA, Leong ML, Bahjat KS, Gao Y, Luckett W, Liu W, Cook DN, Portnoy DA, Dubensky TW. 2004. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci U S A 101:13832-13837. https://doi.org/10.1073/pnas.0406035101.
34. Sauer J-D, Pereyre S, Archer KA, Burke TP, Hanson B, Lauer P, Portnoy DA. 2011 Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity. Proc Natl Acad Sci U S A 108:12419-12424. https://doi.org/10.1073/pnas.1019041108.
35. Glomski IJ, Decatur AL, Portnoy DA. 2003. Listeria monocytogenes mutants that fail to compartmentalize listerolysin O activity are cytotoxic, avirulent, and unable to evade host extracellular defenses. Infect Immun 71:6754-6765. https://doi.org/10.1128/IAI.71.12.6754-6765.2003.
36. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DCS. 1998. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17:384-395. https://doi.org/10.1093/emboj/17.2.384.
37. Pamer EG. 2004. Immune responses to Listeria monocytogenes. Nat Rev Immunol 4:812-823. https://doi.org/10.1038/nri1461.
38. Freeman MM, Ziegler HK. 2005. Simultaneous Th1-type cytokine expression is a signature of peritoneal CD4+ lymphocytes responding to infection with Listeria monocytogenes. J Immunol 175:394-403. https://doi.org/10.4049/jimmunol.175.1.394.
39. Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4:225-234.
40. Schiemann M, Busch V, Linkemann K, Huster KM, Busch DH. 2003. Differences in maintenance of CD8+ and CD4+ bacteria-specific effector-memory T cell populations. Eur J Immunol 33:2875-2885. https://doi.org/10.1002/eji.200324224.
41. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM, Pamer EG. 2000. Early programming of T cell populations responding to bacterial infection. J Immunol 165:6833-6839. https://doi.org/10.4049/jimmunol.165.12.6833.
42. Skoberne M, Holtappels R, Hof H, Geginat G. 2001. Dynamic antigen presentation patterns of Listeria monocytogenes-derived CD8 T cell epitopes in vivo. J Immunol 167:2209-2218. https://doi.org/10.4049/jimmunol.167.4.2209.
43. Karttunen J, Sanderson S, Shastri N. 1992. Detection of rare antigenpresenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 89:6020-6024. https://doi.org/10.1073/pnas.89.13.6020.
44. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. 2006. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211:81-92. https://doi.org/10.1111/j.0105-2896.2006.00382.x.
45. Richer MJ, Nolz JC, Harty JT. 2013. Pathogen-specific inflammatory milieux tune the antigen sensitivity of CD8(+) T cells by enhancing T cell receptor signaling. Immunity 38:140-152. https://doi.org/10.1016/j.immuni.2012.09.017.
46. Carrero JA, Calderon B, Unanue ER. 2004. Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J Immunol 172:4866-4874. https://doi.org/10.4049/jimmunol.172.8.4866.
47. Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F, Greten TF. 2007. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 178:1573-1580. https://doi.org/10.4049/jimmunol.178.3.1573.
48. Cella M. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747-752. https://doi.org/10.1084/jem.184.2.747.
49. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. 1998 Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480. https://doi.org/10.1038/30996.
50. Keane J, Remold HG, Kornfeld H. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 164:2016-2020. https://doi.org/10.4049/jimmunol.164.4.2016.
51. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL, Brinkmann V, Kaufmann SHE. 2003. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 9:1039-1046. https://doi.org/10.1038/nm906.
52. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. 1998 Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101: 890-898. https://doi.org/10.1172/JCI1112.
53. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. 1997. Immunosuppressive effects of apoptotic cells. Nature 390:350-351. https://doi.org/10.1038/37022.
54. Stuart LM, Lucas M, Simpson C, Lamb J, Savill J, Lacy-Hulbert A. 2002. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 168:1627-1635. https://doi.org/10.4049/jimmunol.168.4.1627.
55. Torchinsky MB, Garaude J, Martin AP, Blander JM. 2009. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458:78-82. https://doi.org/10.1038/nature07781.
56. Xu S, Han Y, Xu X, Bao Y, Zhang M, Cao X. 2010. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol 185:5879-5887. https://doi.org/10.4049/jimmunol.1001763.
57. Pick J, Arra A, Lingel H, Hegel JK, Huber M, Nishanth G, Jorch G, Fischer K-D, Schlüter D, Tedford K, Brunner-Weinzierl MC. 2014. CTLA-4 (CD152) enhances the Tc17 differentiation program. Eur J Immunol 44: 2139-2152. https://doi.org/10.1002/eji.201343497.
58. Williams CR, Dustin ML, Sauer J-D. 2013. Inflammasome-mediated inhibition of Listeria monocytogenes-stimulated immunity is independent of myelomonocytic function. PLoS One 8:e83191. https://doi.org/10.1371/journal.pone.0083191.
59. Kim MT, Kurup SP, Starbeck-Miller GR, Harty JT. 2016. Manipulating memory CD8 T cell numbers by timed enhancement of IL-2 signals. J Immunol 197:1754-1761. https://doi.org/10.4049/jimmunol.1600641.
60. von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, Brown CR, Krantz BA, Leppla SH, Gronert K, Vance RE. 2012. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490:107-111. https://doi.org/10.1038/nature11351.
61. Ahmadi M, Emery DC, Morgan DJ. 2008. Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo. Cancer Res 68: 7520-7529. https://doi.org/10.1158/0008-5472.CAN-08-1060.
62. Betz M, Fox BS. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146:108-113.
63. Baratelli F, Lin Y, Zhu L, Yang S-C, Heuzé-Vourc'h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM. 2005. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 175:1483-1490. https://doi.org/10.4049/jimmunol.175.3.1483.
64. Griffith TS, Ferguson TA. 2011. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 35: 456-466. https://doi.org/10.1016/j.immuni.2011.08.011.
65. Archer KA, Durack J, Portnoy DA. 2014. STING-dependent type I IFN production inhibits cell-mediated immunity to Listeria monocytogenes. PLoS Pathog 10:e1003861. https://doi.org/10.1371/journal.ppat.1003861.
66. Lauer P, Chow MYN, Loessner MJ, Portnoy DA, Calendar R. 2002. Construction, characterization, and use of two Listeria monocytogenes sitespecific phage integration vectors. J Bacteriol 184:4177-4186. https://doi.org/10.1128/JB.184.15.4177-4186.2002.
67. Camilli A, Tilney LG, Portnoy DA. 1993. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol Microbiol 8:143-157. https://doi.org/10.1111/j.1365-2958.1993.tb01211.x.
68. Portnoy DA, Jacks PS, Hinrichs DJ. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 167: 1459-1471. https://doi.org/10.1084/jem.167.4.1459.
69. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, Schuler G. 1999 An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92. https://doi.org/10.1016/S0022-1759(98)00204-X.
70. Ripio MT, Brehm K, Lara M, Suárez M, Vázquez-Boland JA. 1997. Glucose-1-phosphate utilization by Listeria monocytogenes is PrfA dependent and coordinately expressed with virulence factors. J Bacteriol 179: 7174-7180.
71. Lauer P, Hanson B, Lemmens EE, Liu W, Luckett WS, Leong ML, Allen HE, Skoble J, Bahjat KS, Freitag NE, Brockstedt DG, Dubensky TW. 2008. Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains. Infect Immun 76:3742-3753. https://doi.org/10.1128/IAI.00390-08.
72. Köhler S, Bubert A, Vogel M, Goebel W. 1991. Expression of the iap gene coding for protein p60 of Listeria monocytogenes is controlled on the posttranscriptional level. J Bacteriol 173:4668-4674. https://doi.org/10.1128/jb.173.15.4668-4674.1991.
73. Gubbels M-J, Striepen B, Shastri N, Turkoz M, Robey EA. 2005. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii. Infect Immun 73:703-711. https://doi.org/10.1128/IAI.73.2.703-711.2005.
74. Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill AV, Bartholomay LC, Harty JT. 2008. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A 105:14017-14022. https://doi.org/10.1073/pnas.0805452105.
75. Decker T, Lohmann-Matthes ML. 1988. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115:61-69. https://doi.org/10.1016/0022-1759(88)90310-9.